An unprecedented epidemic of Ebola virus disease has ravaged West Africa since December, 2013. The French nongovernmental organization Alliance for International Medical Action opened the N’zérékoré Ebola treatment center (ETC) on December 2nd, 2014. This center includes a laboratory managed by the Belgian organization B-Fast/B-Life. Between December 2nd, 2014, and February 7th, 2015, 130 patients were admitted, of whom 76 were confirmed to have Ebola virus disease (EVD), which was fatal in 60.8%. Since December 26th, 2014, the N’zérékoré ETC has been a clinical trial site, participating in a multicenter study to evaluate the ability of a 10-day course of the oral antiviral agent favipiravir to reduce mortality in Ebola-infected adults and children aged over 1 year.
Palich, R., Gala, J.-L., Petitjean, F., Shepherd, S., Peyrouset, O., Abdoul, B. M., Kinda, M., Danel, C., Augier, A., Anglaret, X., Malvy, D., Blackwell, N., & ALIMA N’zérékoré Ebola Treatment Center medical group. (2016). A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea. PLoS Neglected Tropical Diseases, 10(3), e0004393 [1-5]. https://doi.org/10.1371/journal.pntd.0004393 (Original work published 2016)